An initial US Food and Drug Administration (FDA) study on kratom, a plant-based substance long consumed in Southeast Asia, has found that the compound appears safe when used in capsule form, even ...
Wednesday, the FDA approved Merck & Co Inc’s (NYSE ... MPM is a rare, aggressive cancer that forms in the lining of the lungs and chest. The approval is based on pivotal Phase 2/3 IND.
the most common form of breast cancer. Last year, the FDA approved Eli Lilly’s CDK4/6 inhibitor, abemaciclib or Verzenio, for use in stage 2 and 3 HR positive, HER2 negative breast cancer ...
The approval marks first indication for Keytruda in MPM in the US, MPM is a rare, aggressive cancer around the lining of the lungs and chest Wednesday, the FDA approved Merck & Co Inc’s MRK ...
The enzyme KRas has become a popular cancer target for drugmakers in the last decade, with many companies developing small molecules that inhibit one or multiple KRas mutants. Now, scientists are ...
She was sentenced to a 10-month ICO and ordered to complete 75 hours of community service for faking the medical certificates. She was also convicted of the drug offences, fined $750, and ...